BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kosiewicz MM, Nast CC, Krishnan A, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Kozaiwa K, Cominelli F. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest. 2001;107:695-702. [PMID: 11254669 DOI: 10.1172/jci10956] [Cited by in Crossref: 194] [Cited by in F6Publishing: 207] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Szczepanski HE, Flannigan KL, Mainoli B, Alston L, Baruta GM, Lee JW, Venu VKP, Shearer J, Dufour A, Hirota SA. NR4A1 modulates intestinal smooth muscle cell phenotype and dampens inflammation-associated intestinal remodeling. FASEB J 2022;36:e22609. [PMID: 36250380 DOI: 10.1096/fj.202101817RR] [Reference Citation Analysis]
2 Li W, Sheng Y, Wang J, Wu S, Han C. MicroRNA‐9a‐5p‐NOX4 inhibits intestinal inflammatory injury by regulating the M1 polarization of intestinal macrophages. J Biochem & Molecular Tox 2022. [DOI: 10.1002/jbt.23245] [Reference Citation Analysis]
3 Nonnecke EB, Castillo PA, Akahoshi DT, Goley SM, Bevins CL, Lönnerdal B. Characterization of an intelectin-1 (Itln1) knockout mouse model. Front Immunol 2022;13:894649. [PMID: 36072603 DOI: 10.3389/fimmu.2022.894649] [Reference Citation Analysis]
4 Xie Y, Fontenot L, Chupina Estrada A, Nelson B, Wang J, Shih DQ, Ho W, Mattai SA, Rieder F, Jensen DD, Bunnett NW, Koon HW. Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2. Cell Mol Gastroenterol Hepatol 2022;14:841-76. [PMID: 35840034 DOI: 10.1016/j.jcmgh.2022.06.011] [Reference Citation Analysis]
5 Garabatos N, Santamaria P. Gut Microbial Antigenic Mimicry in Autoimmunity. Front Immunol 2022;13:873607. [PMID: 35572569 DOI: 10.3389/fimmu.2022.873607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Iliopoulou L, Kollias G. Harnessing murine models of Crohn's disease ileitis to advance concepts of pathophysiology and treatment. Mucosal Immunol 2022;15:10-26. [PMID: 34316007 DOI: 10.1038/s41385-021-00433-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Baydi Z, Limami Y, Khalki L, Zaid N, Naya A, Mtairag EM, Oudghiri M, Zaid Y. An Update of Research Animal Models of Inflammatory Bowel Disease. ScientificWorldJournal 2021;2021:7479540. [PMID: 34938152 DOI: 10.1155/2021/7479540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Verma A, Sharda S, Rathi B, Somvanshi P, Pandey BD. Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach. Sci Rep 2020;10:15131. [PMID: 32934294 DOI: 10.1038/s41598-020-71674-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hu WC. A Framework of All Discovered Immunological Pathways and Their Roles for Four Specific Types of Pathogens and Hypersensitivities. Front Immunol 2020;11:1992. [PMID: 32849663 DOI: 10.3389/fimmu.2020.01992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
10 Buttó LF, Pelletier A, More SK, Zhao N, Osme A, Hager CL, Ghannoum MA, Sekaly RP, Cominelli F, Dave M. Intestinal Stem Cell Niche Defects Result in Impaired 3D Organoid Formation in Mouse Models of Crohn's Disease-like Ileitis. Stem Cell Reports 2020;15:389-407. [PMID: 32679063 DOI: 10.1016/j.stemcr.2020.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mizoguchi E, Low D, Ezaki Y, Okada T. Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models. Intest Res. 2020;18:151-167. [PMID: 32326669 DOI: 10.5217/ir.2019.09154] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 17.7] [Reference Citation Analysis]
12 Dillon A, Lo DD. M Cells: Intelligent Engineering of Mucosal Immune Surveillance. Front Immunol 2019;10:1499. [PMID: 31312204 DOI: 10.3389/fimmu.2019.01499] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 15.8] [Reference Citation Analysis]
13 Li J, Zuo L, Tian Y, He Y, Zhang Z, Guo P, Ge Y, Hu J. Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting glutaminase1. J Cell Mol Med 2019;23:5632-41. [PMID: 31211512 DOI: 10.1111/jcmm.14471] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
14 Di Martino L, Osme A, Kossak-Gupta S, Pizarro TT, Cominelli F. TWEAK/Fn14 Is Overexpressed in Crohn's Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways. Cell Mol Gastroenterol Hepatol 2019;8:427-46. [PMID: 31181286 DOI: 10.1016/j.jcmgh.2019.05.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Dosh RH, Jordan-Mahy N, Sammon C, Le Maitre C. Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model. Oncotarget 2019;10:3559-75. [PMID: 31191826 DOI: 10.18632/oncotarget.26894] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
16 Schulte L, Hohwieler M, Müller M, Klaus J. Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease. Stem Cells Int 2019;2019:8010645. [PMID: 31015842 DOI: 10.1155/2019/8010645] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
17 Buttó LF, Jia LG, Arseneau KO, Tamagawa H, Rodriguez-Palacios A, Li Z, De Salvo C, Pizarro TT, Bamias G, Cominelli F. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease. Inflamm Bowel Dis 2019;25:14-26. [PMID: 30295722 DOI: 10.1093/ibd/izy305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 He P, Haque A, Lin S, Cominelli F, Yun CC. Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na(+)/H(+) exchanger 3 in SAMP1/Fc mice. Am J Physiol Gastrointest Liver Physiol 2018;315:G762-71. [PMID: 30118349 DOI: 10.1152/ajpgi.00215.2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
19 Rezende KS, Fernandes MR, Faria BBD, Guimarães RCA, Freitas KC. Use of Animal Models in the Study of Colitis. Experimental Animal Models of Human Diseases - An Effective Therapeutic Strategy 2018. [DOI: 10.5772/intechopen.75608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Li Z, Buttó LF, Buela KA, Jia LG, Lam M, Ward JD, Pizarro TT, Cominelli F. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis. Front Immunol 2018;9:362. [PMID: 29545797 DOI: 10.3389/fimmu.2018.00362] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kim C. The Gastrointestinal Immune System. Comprehensive Toxicology 2018. [DOI: 10.1016/b978-0-12-801238-3.02120-6] [Reference Citation Analysis]
22 Bettenworth D. Animal Models and Sources of Mesenchymal Cells in Intestinal Fibrosis. Fibrostenotic Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-3-319-90578-5_9] [Reference Citation Analysis]
23 Cao W, Kayama H, Chen ML, Delmas A, Sun A, Kim SY, Rangarajan ES, McKevitt K, Beck AP, Jackson CB, Crynen G, Oikonomopoulos A, Lacey PN, Martinez GJ, Izard T, Lorenz RG, Rodriguez-Palacios A, Cominelli F, Abreu MT, Hommes DW, Koralov SB, Takeda K, Sundrud MS. The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids. Immunity 2017;47:1182-1196.e10. [PMID: 29262351 DOI: 10.1016/j.immuni.2017.11.012] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 8.3] [Reference Citation Analysis]
24 Dunkin D, Berin MC, Mondoulet L, Tobar S, Yeretssian G, Tordesillas L, Iuga A, Larcher T, Gillespie V, Benhamou PH, Colombel JF, Sampson HA. Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice. Inflamm Bowel Dis 2017;23:1972-82. [PMID: 29019858 DOI: 10.1097/MIB.0000000000001273] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
25 Cominelli F, Arseneau KO, Rodriguez-Palacios A, Pizarro TT. Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model? Cell Mol Gastroenterol Hepatol 2017;4:19-32. [PMID: 28560286 DOI: 10.1016/j.jcmgh.2017.02.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
26 Lopetuso LR, Jia R, Wang XM, Jia LG, Petito V, Goodman WA, Meddings JB, Cominelli F, Reuter BK, Pizarro TT. Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis. Inflamm Bowel Dis 2017;23:392-403. [PMID: 28146004 DOI: 10.1097/MIB.0000000000001035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
27 Webb CR, Grisham MB. Mouse Models of Chronic Intestinal Inflammation: Characterization and Use in Pharmacological Intervention Studies. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_15] [Reference Citation Analysis]
28 Do JS, Kim S, Keslar K, Jang E, Huang E, Fairchild RL, Pizarro TT, Min B. γδ T Cells Coexpressing Gut Homing α4β7 and αE Integrins Define a Novel Subset Promoting Intestinal Inflammation. J Immunol 2017;198:908-15. [PMID: 27927968 DOI: 10.4049/jimmunol.1601060] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
29 Di Martino L, Dave M, Menghini P, Xin W, Arseneau KO, Pizarro TT, Cominelli F. Protective Role for TWEAK/Fn14 in Regulating Acute Intestinal Inflammation and Colitis-Associated Tumorigenesis. Cancer Res 2016;76:6533-42. [PMID: 27634763 DOI: 10.1158/0008-5472.CAN-16-0400] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
30 Roulis M, Bongers G, Armaka M, Salviano T, He Z, Singh A, Seidler U, Becker C, Demengeot J, Furtado GC, Lira SA, Kollias G. Host and microbiota interactions are critical for development of murine Crohn's-like ileitis. Mucosal Immunol 2016;9:787-97. [PMID: 26487367 DOI: 10.1038/mi.2015.102] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
31 Chen ML, Sundrud MS. Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2016;22:1157-67. [PMID: 26863267 DOI: 10.1097/MIB.0000000000000714] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 11.9] [Reference Citation Analysis]
32 Chen ML, Sundrud MS. Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2016;22:1157-67. [PMID: 26863267 DOI: 10.1097/MIB.0000000000000714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 De Salvo C, Wang XM, Pastorelli L, Mattioli B, Omenetti S, Buela KA, Chowdhry S, Garg RR, Goodman WA, Rodriguez-Palacios A, Smith DE, Abbott DW, Cominelli F, Bamias G, Xin W, Lee JJ, Vecchi M, Pizarro TT. IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis. Am J Pathol 2016;186:885-98. [PMID: 26908008 DOI: 10.1016/j.ajpath.2015.11.028] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
34 Castro-Mejía J, Jakesevic M, Krych Ł, Nielsen DS, Hansen LH, Sondergaard BC, Kvist PH, Hansen AK, Holm TL. Treatment with a Monoclonal Anti-IL-12p40 Antibody Induces Substantial Gut Microbiota Changes in an Experimental Colitis Model. Gastroenterol Res Pract 2016;2016:4953120. [PMID: 26880890 DOI: 10.1155/2016/4953120] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
35 Rodriguez-Palacios A, Kodani T, Kaydo L, Pietropaoli D, Corridoni D, Howell S, Katz J, Xin W, Pizarro TT, Cominelli F. Stereomicroscopic 3D-pattern profiling of murine and human intestinal inflammation reveals unique structural phenotypes. Nat Commun 2015;6:7577. [PMID: 26154811 DOI: 10.1038/ncomms8577] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
36 Omenetti S, Brogi M, Goodman WA, Croniger CM, Eid S, Huang AY, Laffi G, Roskams T, Cominelli F, Pinzani M, Pizarro TT. Dysregulated intrahepatic CD4(+) T-cell activation drives liver inflammation in ileitis-prone SAMP1/YitFc mice. Cell Mol Gastroenterol Hepatol 2015;1:406-19. [PMID: 26213712 DOI: 10.1016/j.jcmgh.2015.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
37 Mikulski Z, Johnson R, Shaked I, Kim G, Nowyhed H, Goodman W, Chodaczek G, Pizarro TT, Cominelli F, Ley K. SAMP1/YitFc mice develop ileitis via loss of CCL21 and defects in dendritic cell migration. Gastroenterology 2015;148:783-793.e5. [PMID: 25620669 DOI: 10.1053/j.gastro.2015.01.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
38 Tahara M, Kondo Y, Yokosawa M, Tsuboi H, Takahashi S, Shibayama S, Matsumoto I, Sumida T. T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death-1-deficient mice. Clin Exp Immunol 2015;179:197-209. [PMID: 25219397 DOI: 10.1111/cei.12455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
39 Dubé PE, Punit S, Polk DB. Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2015;308:G161-70. [PMID: 25477373 DOI: 10.1152/ajpgi.00142.2014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
40 De Salvo C, Ray S, Pizarro TT. Mechanisms and models for intestinal fibrosis in IBD. Dig Dis 2014;32 Suppl 1:26-34. [PMID: 25531350 DOI: 10.1159/000367822] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
41 Zuo L, Li Y, Wang H, Wu R, Zhu W, Zhang W, Cao L, Gu L, Gong J, Li N, Li J. Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice. J Crohns Colitis 2014;8:1710-22. [PMID: 25205553 DOI: 10.1016/j.crohns.2014.08.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
42 Ansary MM, Ishihara S, Oka A, Kusunoki R, Oshima N, Yuki T, Kawashima K, Maegawa H, Kashiwagi N, Kinoshita Y. Apoptotic cells ameliorate chronic intestinal inflammation by enhancing regulatory B-cell function. Inflamm Bowel Dis 2014;20:2308-20. [PMID: 25358066 DOI: 10.1097/MIB.0000000000000240] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
43 Ray S, De Salvo C, Pizarro TT. Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis. Curr Opin Gastroenterol 2014;30:531-8. [PMID: 25255234 DOI: 10.1097/MOG.0000000000000119] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
44 Sylvester FA, Draghi A, Menoret A, Fernandez ML, Wang Z, Vella AT. Distinctive Colonic Mucosal Cytokine Signature in New-Onset, Untreated Pediatric Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 2014;59:553-561. [DOI: 10.1097/mpg.0000000000000480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
45 Zhang J, Fu S, Sun S, Li Z, Guo B. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol 2014;7:1139-50. [PMID: 24472848 DOI: 10.1038/mi.2014.1] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 10.3] [Reference Citation Analysis]
46 Oka A, Ishihara S, Mishima Y, Tada Y, Kusunoki R, Fukuba N, Yuki T, Kawashima K, Matsumoto S, Kinoshita Y. Role of regulatory B cells in chronic intestinal inflammation: association with pathogenesis of Crohn's disease. Inflamm Bowel Dis 2014;20:315-28. [PMID: 24390063 DOI: 10.1097/01.MIB.0000437983.14544.d5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
47 Signore A, de Vries EFJ, Galli F, Malviya G. Applications of Molecular Small-Animal Imaging in Inflammation and Infection. Molecular Imaging of Small Animals 2014. [DOI: 10.1007/978-1-4939-0894-3_22] [Reference Citation Analysis]
48 Valatas V, Vakas M, Kolios G. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol 2013;305:G763-85. [PMID: 23989010 DOI: 10.1152/ajpgi.00004.2013] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
49 Pastorelli L, De Salvo C, Mercado JR, Vecchi M, Pizarro TT. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol. 2013;4:280. [PMID: 24062746 DOI: 10.3389/fimmu.2013.00280] [Cited by in Crossref: 283] [Cited by in F6Publishing: 295] [Article Influence: 28.3] [Reference Citation Analysis]
50 Bamias G, Dahman MI, Arseneau KO, Guanzon M, Gruska D, Pizarro TT, Cominelli F. Intestinal-specific TNFα overexpression induces Crohn's-like ileitis in mice. PLoS One 2013;8:e72594. [PMID: 23977323 DOI: 10.1371/journal.pone.0072594] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
51 Ishikawa D, Okazawa A, Corridoni D, Jia LG, Wang XM, Guanzon M, Xin W, Arseneau KO, Pizarro TT, Cominelli F. Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease. Mucosal Immunol 2013;6:267-75. [PMID: 22785225 DOI: 10.1038/mi.2012.67] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
52 Mizoguchi A, Andoh A. Animal Models of Inflammatory Bowel Disease for Drug Discovery. Animal Models for the Study of Human Disease 2013. [DOI: 10.1016/b978-0-12-415894-8.00022-1] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
53 Mizoguchi E, Mizoguchi A, Bhan AK. Insights from Recent Advances in Animal Models of Inflammatory Bowel Disease. Molecular Genetics of Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-8256-7_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Rieder F, Kessler S, Sans M, Fiocchi C. Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease. Am J Physiol Gastrointest Liver Physiol 2012;303:G786-801. [PMID: 22878121 DOI: 10.1152/ajpgi.00059.2012] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 8.7] [Reference Citation Analysis]
55 Corridoni D, Pastorelli L, Mattioli B, Locovei S, Ishikawa D, Arseneau KO, Chieppa M, Cominelli F, Pizarro TT. Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. PLoS One. 2012;7:e42067. [PMID: 22848704 DOI: 10.1371/journal.pone.0042067] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 7.4] [Reference Citation Analysis]
56 Ernst PB, Erickson LD, Loo WM, Scott KG, Wiznerowicz EB, Brown CC, Torres-Velez FJ, Alam MS, Black SG, McDuffie M, Feldman SH, Wallace JL, McKnight GW, Padol IT, Hunt RH, Tung KS. Spontaneous autoimmune gastritis and hypochlorhydria are manifest in the ileitis-prone SAMP1/YitFcs mice. Am J Physiol Gastrointest Liver Physiol 2012;302:G105-15. [PMID: 21921286 DOI: 10.1152/ajpgi.00194.2011] [Reference Citation Analysis]
57 Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci 2012;105:263-320. [PMID: 22137435 DOI: 10.1016/B978-0-12-394596-9.00009-3] [Cited by in Crossref: 166] [Cited by in F6Publishing: 171] [Article Influence: 15.1] [Reference Citation Analysis]
58 Karlsson F, Koboziev I, Grisham MB. Preclinical Studies Using Mouse Models of Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2012. [DOI: 10.1007/978-1-4614-0998-4_16] [Reference Citation Analysis]
59 Pizarro TT, Pastorelli L, Bamias G, Garg RR, Reuter BK, Mercado JR, Chieppa M, Arseneau KO, Ley K, Cominelli F. SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis. Inflamm Bowel Dis 2011;17:2566-84. [PMID: 21557393 DOI: 10.1002/ibd.21638] [Cited by in Crossref: 121] [Cited by in F6Publishing: 116] [Article Influence: 10.1] [Reference Citation Analysis]
60 Reuter BK, Pastorelli L, Brogi M, Garg RR, McBride JA, Rowlett RM, Arrieta MC, Wang XM, Keller EJ, Feldman SH, Mize JR, Cominelli F, Meddings JB, Pizarro TT. Spontaneous, immune-mediated gastric inflammation in SAMP1/YitFc mice, a model of Crohn's-like gastritis. Gastroenterology 2011;141:1709-19. [PMID: 21704001 DOI: 10.1053/j.gastro.2011.06.041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
61 Masterson JC, McNamee EN, Jedlicka P, Fillon S, Ruybal J, Hosford L, Rivera-Nieves J, Lee JJ, Furuta GT. CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling. Am J Pathol 2011;179:2302-14. [PMID: 21945903 DOI: 10.1016/j.ajpath.2011.07.039] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
62 Andreu-Ballester JC, Amigó-García V, Catalán-Serra I, Gil-Borrás R, Ballester F, Almela-Quilis A, Millan-Scheiding M, Peñarroja-Otero C. Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn's disease. Dig Dis Sci 2011;56:2613-22. [PMID: 21374064 DOI: 10.1007/s10620-011-1636-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
63 Koboziev I, Karlsson F, Zhang S, Grisham MB. Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis 2011;17:1229-45. [PMID: 21312318 DOI: 10.1002/ibd.21557] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
64 Kerr WG, Park MY, Maubert M, Engelman RW. SHIP deficiency causes Crohn's disease-like ileitis. Gut 2011;60:177-88. [PMID: 20940287 DOI: 10.1136/gut.2009.202283] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
65 Shih DQ, Barrett R, Zhang X, Yeager N, Koon HW, Phaosawasdi P, Song Y, Ko B, Wong MH, Michelsen KS. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PLoS One. 2011;6:e16090. [PMID: 21264313 DOI: 10.1371/journal.pone.0016090] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 6.3] [Reference Citation Analysis]
66 Boschetti G, Nancey S, Sardi F, Roblin X, Flourié B, Kaiserlian D. Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:160-70. [PMID: 20848510 DOI: 10.1002/ibd.21308] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
67 Mishima Y, Ishihara S, Aziz MM, Oka A, Kusunoki R, Otani A, Tada Y, Li YY, Moriyama I, Oshima N, Yuki T, Amano Y, Matsumoto S, Kinoshita Y. Decreased production of interleukin-10 and transforming growth factor-β in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice. Immunology 2010;131:473-87. [PMID: 20561083 DOI: 10.1111/j.1365-2567.2010.03318.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
68 Gorfu G, Rivera-Nieves J, Hoang S, Abbott DW, Arbenz-Smith K, Azar DW, Pizarro TT, Cominelli F, McDuffie M, Ley K. Beta7 integrin deficiency suppresses B cell homing and attenuates chronic ileitis in SAMP1/YitFc mice. J Immunol 2010;185:5561-8. [PMID: 20926792 DOI: 10.4049/jimmunol.0903938] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
69 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225] [Cited by in Crossref: 1352] [Cited by in F6Publishing: 1433] [Article Influence: 104.0] [Reference Citation Analysis]
71 McNamee EN, Wermers JD, Masterson JC, Collins CB, Lebsack MD, Fillon S, Robinson ZD, Grenawalt J, Lee JJ, Jedlicka P, Furuta GT, Rivera-Nieves J. Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. Inflamm Bowel Dis 2010;16:743-52. [PMID: 19856411 DOI: 10.1002/ibd.21148] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
72 Kim C, Shanahan F. The Gastrointestinal Immune System*. Comprehensive Toxicology 2010. [DOI: 10.1016/b978-0-08-046884-6.00843-5] [Reference Citation Analysis]
73 Gálvez J, Comalada M, Xaus J. Prebiotics and Probiotics in Experimental Models of Rodent Colitis. Bioactive Foods in Promoting Health 2010. [DOI: 10.1016/b978-0-12-374938-3.00035-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Ben Alaya W, Sfar I, Aouadi H, Jendoubi S, Najjar T, Filali A, Gorgi Y, Ben Abdallah T, Mouelhi L, Matri S. Association between CTLA-4 gene promoter (49 A/G) in exon 1 polymorphisms and inflammatory bowel disease in the Tunisian population. Saudi J Gastroenterol. 2009;15:29-34. [PMID: 19568552 DOI: 10.4103/1319-3767.43285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
75 Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA. 2010;107:454-459. [PMID: 20018654 DOI: 10.1073/pnas.0910307107] [Cited by in Crossref: 242] [Cited by in F6Publishing: 251] [Article Influence: 17.3] [Reference Citation Analysis]
76 Muñoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, Plickert R, Bereswill S, Fischer A, Dunay IR, Wolk K, Loddenkemper C, Krell HW, Libert C, Lund LR, Frey O, Hölscher C, Iwakura Y, Ghilardi N, Ouyang W, Kamradt T, Sabat R, Liesenfeld O. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med 2009;206:3047-59. [PMID: 19995958 DOI: 10.1084/jem.20090900] [Cited by in Crossref: 204] [Cited by in F6Publishing: 220] [Article Influence: 14.6] [Reference Citation Analysis]
77 Matsunaga H, Hokari R, Kurihara C, Okada Y, Takebayashi K, Okudaira K, Watanabe C, Komoto S, Nakamura M, Tsuzuki Y. Omega-3 polyunsaturated fatty acids ameliorate the severity of ileitis in the senescence accelerated mice (SAM)P1/Yit mice model. Clin Exp Immunol. 2009;158:325-333. [PMID: 19793338 DOI: 10.1111/j.1365-2249.2009.04020.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
78 Maynard CL, Weaver CT. Intestinal effector T cells in health and disease. Immunity. 2009;31:389-400. [PMID: 19766082 DOI: 10.1016/j.immuni.2009.08.012] [Cited by in Crossref: 135] [Cited by in F6Publishing: 119] [Article Influence: 9.6] [Reference Citation Analysis]
79 Rigby RJ, Hunt MR, Scull BP, Simmons JG, Speck KE, Helmrath MA, Lund PK. A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora. Gut 2009;58:1104-12. [PMID: 19398439 DOI: 10.1136/gut.2008.157636] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
80 McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009;15:100-13. [PMID: 18623167 DOI: 10.1002/ibd.20539] [Cited by in Crossref: 387] [Cited by in F6Publishing: 388] [Article Influence: 27.6] [Reference Citation Analysis]
81 Rivera-Nieves J, Gorfu G, Ley K. Leukocyte adhesion molecules in animal models of inflammatory bowel disease. Inflamm Bowel Dis 2008;14:1715-35. [PMID: 18523998 DOI: 10.1002/ibd.20501] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
82 Matsumoto S, Hara T, Nagaoka M, Mike A, Mitsuyama K, Sako T, Yamamoto M, Kado S, Takada T. A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer. Immunology. 2009;128:e170-e180. [PMID: 19740306 DOI: 10.1111/j.1365-2567.2008.02942.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 5.0] [Reference Citation Analysis]
83 Grisham MB. Do different animal models of IBD serve different purposes? Inflamm Bowel Dis 2008;14 Suppl 2:S132-3. [PMID: 18816751 DOI: 10.1002/ibd.20682] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
84 Eksteen B, Liaskou E, Adams DH. Lymphocyte homing and its role in the pathogenesis of IBD. Inflamm Bowel Dis 2008;14:1298-312. [PMID: 18393377 DOI: 10.1002/ibd.20453] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
85 Murphy CG, Glickman JN, Tomczak K, Wang YY, Beggs AH, Shannon MW, Horwitz BH. Acute appendicitis is characterized by a uniform and highly selective pattern of inflammatory gene expression. Mucosal Immunol 2008;1:297-308. [PMID: 19079191 DOI: 10.1038/mi.2008.13] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
86 Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Müller W, Papadakis KA, Kontoyiannis DL, Malissen B, Kollias G. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease. Gastroenterology 2008;134:2025-35. [PMID: 18439426 DOI: 10.1053/j.gastro.2008.02.085] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 5.2] [Reference Citation Analysis]
87 Arseneau KO, Tamagawa H, Pizarro TT, Cominelli F. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep. 2007;9:508-512. [PMID: 18377804 DOI: 10.1007/s11894-007-0067-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 4.4] [Reference Citation Analysis]
88 Cohn SM, Vidrich A. Response to Comment on “Resistin-Like Molecule β (RELM β/FIZZ2) Is Highly Expressed in the Ileum of SAMP1/YitFc Mice and Is Associated with Initiation of Ileitis”. J Immunol 2008;180:2009.2-2010. [DOI: 10.4049/jimmunol.180.4.2009-a] [Reference Citation Analysis]
89 Rowlett RM, Chrestensen CA, Nyce M, Harp MG, Pelo JW, Cominelli F, Ernst PB, Pizarro TT, Sturgill TW, Worthington MT. MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages. Am J Physiol Gastrointest Liver Physiol 2008;294:G452-9. [PMID: 18032482 DOI: 10.1152/ajpgi.00077.2007] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
90 Dinarello CA. Historical insights into cytokines. Eur J Immunol. 2007;37 Suppl 1:S34-S45. [PMID: 17972343 DOI: 10.1002/eji.200737772] [Cited by in Crossref: 482] [Cited by in F6Publishing: 502] [Article Influence: 32.1] [Reference Citation Analysis]
91 Rescigno M, Mileti E. Interactions between Epithelial Cells and Dendritic Cells in Bacterial Handling. Bioscience Microflora 2008;27:113-22. [DOI: 10.12938/bifidus.27.113] [Reference Citation Analysis]
92 Tello-ruiz MK, Walsh EC, Rioux JD. Gastroenterologic and Hepatic Diseases. Immunogenetics of Autoimmune Disease. [DOI: 10.1007/978-0-387-39926-3_7] [Reference Citation Analysis]
93 Atreya R, Waldner M, Neurath MF. Animal models in inflammatory bowel disease. Falk Symposium. [DOI: 10.1007/978-1-4020-6116-5_6] [Reference Citation Analysis]
94 Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, Gjertson D, Braun J, Reed E, Singh RR. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol. 2008;126:121-136. [PMID: 17916444 DOI: 10.1016/j.clim.2007.08.013] [Cited by in Crossref: 193] [Cited by in F6Publishing: 189] [Article Influence: 12.1] [Reference Citation Analysis]
95 Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007;102:2058-69. [PMID: 17561966 DOI: 10.1111/j.1572-0241.2007.01343.x] [Cited by in Crossref: 158] [Cited by in F6Publishing: 162] [Article Influence: 9.9] [Reference Citation Analysis]
96 Pawlowski NN, Struck D, Grollich K, Kühl AA, Zeitz M, Liesenfeld O, Hoffmann JC. CD2 deficiency partially prevents small bowel inflammation and improves parasite control in murine Toxoplasma gondii infection. World J Gastroenterol 2007; 13(31): 4207-4213 [PMID: 17696249 DOI: 10.3748/wjg.v13.i31.4207] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
97 Cominelli F, Arseneau KO, Pizarro TT. The mucosal inflammatory response. Cytokines and chemokines. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_7] [Reference Citation Analysis]
98 Elson CO, Weaver CT. Experimental mouse models of inflammatory bowel disease: new insights into pathogenic mechanisms. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_4] [Reference Citation Analysis]
99 Rescigno M. Dendritic cell activation and uptake of bacteria in vivo. Dendritic Cell Interactions with Bacteria 2007. [DOI: 10.1017/cbo9780511541551.005] [Reference Citation Analysis]
100 O'Hara AM, Shanahan F. Gut microbiota: mining for therapeutic potential. Clin Gastroenterol Hepatol 2007;5:274-84. [PMID: 17368226 DOI: 10.1016/j.cgh.2006.12.009] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 5.5] [Reference Citation Analysis]
101 Kang SG, Piniecki RJ, Hogenesch H, Lim HW, Wiebke E, Braun SE, Matsumoto S, Kim CH. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine. Gastroenterology 2007;132:966-81. [PMID: 17324406 DOI: 10.1053/j.gastro.2007.01.008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
102 Connors JM. Crohn's Disease of the Stomach and Duodenum. xPharm: The Comprehensive Pharmacology Reference 2007. [DOI: 10.1016/b978-008055232-3.60714-7] [Reference Citation Analysis]
103 Pizarro TT, De La Rue SA, Cominelli F. Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies? Gut 2006;55:1226-7. [PMID: 16905692 DOI: 10.1136/gut.2005.083121] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
104 Mitsuyama K, Matsumoto S, Rose-John S, Suzuki A, Hara T, Tomiyasu N, Handa K, Tsuruta O, Funabashi H, Scheller J, Toyonaga A, Sata M. STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. Gut 2006;55:1263-9. [PMID: 16682432 DOI: 10.1136/gut.2005.079343] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 5.1] [Reference Citation Analysis]
105 Nakamura K, Honda K, Mizutani T, Akiho H, Harada N. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules. World J Gastroenterol 2006; 12(29): 4628-4635 [PMID: 16937430 DOI: 10.3748/wjg.v12.i29.4628] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 80] [Article Influence: 4.5] [Reference Citation Analysis]
106 Nancey S, Holvöet S, Graber I, Joubert G, Philippe D, Martin S, Nicolas JF, Desreumaux P, Flourié B, Kaiserlian D. CD8+ cytotoxic T cells induce relapsing colitis in normal mice. Gastroenterology 2006;131:485-96. [PMID: 16890603 DOI: 10.1053/j.gastro.2006.05.018] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 4.1] [Reference Citation Analysis]
107 Rivera-Nieves J, Burcin TL, Olson TS, Morris MA, McDuffie M, Cominelli F, Ley K. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J Exp Med. 2006;203:907-917. [PMID: 16567389 DOI: 10.1084/jem.20052530] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 4.2] [Reference Citation Analysis]
108 Achkar JP, Dassopoulos T, Silverberg MS, Tuvlin JA, Duerr RH, Brant SR, Siminovitch K, Reddy D, Datta LW, Bayless TM, Zhang L, Barmada MM, Rioux JD, Steinhart AH, McLeod RS, Griffiths AM, Cohen Z, Yang H, Bromfield GP, Schumm P, Hanauer SB, Cho JH, Nicolae DL. Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am J Gastroenterol 2006;101:572-80. [PMID: 16542294 DOI: 10.1111/j.1572-0241.2006.00451.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
109 Olson TS, Reuter BK, Scott KG, Morris MA, Wang XM, Hancock LN, Burcin TL, Cohn SM, Ernst PB, Cominelli F. The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med. 2006;203:541-552. [PMID: 16505137 DOI: 10.1084/jem.20050407] [Cited by in Crossref: 135] [Cited by in F6Publishing: 143] [Article Influence: 7.9] [Reference Citation Analysis]
110 Mueller C, Macpherson AJ. Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 2006;55:276-84. [PMID: 16407387 DOI: 10.1136/gut.2004.054098] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 4.5] [Reference Citation Analysis]
111 Bachmann C, Klibanov AL, Olson TS, Sonnenschein JR, Rivera-Nieves J, Cominelli F, Ley KF, Lindner JR, Pizarro TT. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology 2006;130:8-16. [PMID: 16401463 DOI: 10.1053/j.gastro.2005.11.009] [Cited by in Crossref: 81] [Cited by in F6Publishing: 91] [Article Influence: 4.8] [Reference Citation Analysis]
112 Caprilli R, Angelucci E, Cocco A. Early or late guided missile in the treatment of Crohn's disease? Dig Liver Dis 2005;37:973-9. [PMID: 16169305 DOI: 10.1016/j.dld.2005.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
113 Sanders DS. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease. J Clin Pathol 2005;58:568-72. [PMID: 15917403 DOI: 10.1136/jcp.2004.021840] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 3.9] [Reference Citation Analysis]
114 Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S, Cominelli F. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 2005;129:26-33. [PMID: 16012931 DOI: 10.1053/j.gastro.2005.05.032] [Cited by in Crossref: 168] [Cited by in F6Publishing: 176] [Article Influence: 9.3] [Reference Citation Analysis]
115 Matsuzaki K, Tsuzuki Y, Matsunaga H, Inoue T, Miyazaki J, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin Exp Immunol. 2005;140:22-31. [PMID: 15762871 DOI: 10.1111/j.1365-2249.2005.02742.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 2.4] [Reference Citation Analysis]
116 Abadía-Molina AC, Mizoguchi A, Faubion WA, De Jong YP, Rietdijk ST, Comiskey M, Clarke K, Bhan AK, Terhorst C. In vivo generation of oligoclonal colitic CD4+ T-cell lines expressing a distinct T-cell receptor Vbeta. Gastroenterology 2005;128:1268-77. [PMID: 15887110 DOI: 10.1053/j.gastro.2005.01.060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
117 Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005;128:891-906. [PMID: 15825073 DOI: 10.1053/j.gastro.2005.02.009] [Cited by in Crossref: 329] [Cited by in F6Publishing: 341] [Article Influence: 18.3] [Reference Citation Analysis]
118 Bamias G, Martin C, Mishina M, Ross WG, Rivera-Nieves J, Marini M, Cominelli F. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 2005;128:654-66. [PMID: 15765401 DOI: 10.1053/j.gastro.2004.11.053] [Cited by in Crossref: 125] [Cited by in F6Publishing: 130] [Article Influence: 6.9] [Reference Citation Analysis]
119 Sugawara K, Olson TS, Moskaluk CA, Stevens BK, Hoang S, Kozaiwa K, Cominelli F, Ley KF, McDuffie M. Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc mice and in human Crohn's disease. Gastroenterology 2005;128:351-60. [PMID: 15685547 DOI: 10.1053/j.gastro.2004.11.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 3.6] [Reference Citation Analysis]
120 Wei B, Velazquez P, Turovskaya O, Spricher K, Aranda R, Kronenberg M, Birnbaumer L, Braun J. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A 2005;102:2010-5. [PMID: 15684084 DOI: 10.1073/pnas.0409449102] [Cited by in Crossref: 142] [Cited by in F6Publishing: 146] [Article Influence: 7.9] [Reference Citation Analysis]
121 Sartor RB, Hoentjen F. Proinflammatory Cytokines and Signaling Pathways in Intestinal Innate Immune Cells. Mucosal Immunology 2005. [DOI: 10.1016/b978-012491543-5/50039-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
122 de Jong YP, Terhorst C, Weaver CT, Elson CO. Disease Induction and Prevention in Experimental Models of Inflammatory Bowel Disease. Mucosal Immunology 2005. [DOI: 10.1016/b978-012491543-5/50074-7] [Reference Citation Analysis]
123 Olson TS, Bamias G, Naganuma M, Rivera-Nieves J, Burcin TL, Ross W, Morris MA, Pizarro TT, Ernst PB, Cominelli F, Ley K. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Invest 2004;114:389-98. [PMID: 15286805 DOI: 10.1172/JCI20855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 50] [Article Influence: 0.2] [Reference Citation Analysis]
124 Kirman I, Whelan RL, Nielsen OH. Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004;16:639-41. [PMID: 15201575 DOI: 10.1097/01.meg.0000108345.41221.c2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
125 Matsumoto S. The roles of enteric bacteria on the development of Crohn's disease-like intestinal inflammation in SAMP1/Yit mice. International Congress Series 2004;1260:137-141. [DOI: 10.1016/s0531-5131(03)01602-9] [Reference Citation Analysis]
126 Weinstock JV. Inflammatory Bowel Disease. Infection and Autoimmunity 2004. [DOI: 10.1016/b978-044451271-0.50051-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
127 Lavy A, Naveh Y, Coleman R, Mokady S, Werman MJ. Dietary Dunaliella bardawil, a beta-carotene-rich alga, protects against acetic acid-induced small bowel inflammation in rats. Inflamm Bowel Dis 2003;9:372-9. [PMID: 14671486 DOI: 10.1097/00054725-200311000-00005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
128 Papadakis KA, Treyzon L, Abreu MT, Fleshner PR, Targan SR, Vasiliauskas EA. Infliximab in the treatment of medically refractory indeterminate colitis. Aliment Pharmacol Ther 2003;18:741-7. [PMID: 14510748 DOI: 10.1046/j.1365-2036.2003.01739.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
129 Zheng CQ, Hu GZ, Zeng ZS, Lin LJ, Gu GG. Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning. World J Gastroenterol 2003; 9(8): 1646-1656 [PMID: 12918095 DOI: 10.3748/wjg.v9.i8.1646] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]
130 Kozaiwa K, Sugawara K, Smith MF Jr, Carl V, Yamschikov V, Belyea B, McEwen SB, Moskaluk CA, Pizarro TT, Cominelli F, McDuffie M. Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Gastroenterology 2003;125:477-90. [PMID: 12891551 DOI: 10.1016/s0016-5085(03)00876-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
131 Mizoguchi A, Mizoguchi E, Bhan AK. Immune networks in animal models of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:246-59. [PMID: 12902848 DOI: 10.1097/00054725-200307000-00005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.5] [Reference Citation Analysis]
132 Marini M, Bamias G, Rivera-Nieves J, Moskaluk CA, Hoang SB, Ross WG, Pizarro TT, Cominelli F. TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc Natl Acad Sci USA. 2003;100:8366-8371. [PMID: 12832622 DOI: 10.1073/pnas.1432897100] [Cited by in Crossref: 152] [Cited by in F6Publishing: 162] [Article Influence: 7.6] [Reference Citation Analysis]
133 Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P, Yang C, Desreumaux P, Giovannini M, Cézard JP, Zouali H, Emilie D, Peuchmaur M. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003;52:840-6. [PMID: 12740340 DOI: 10.1136/gut.52.6.840] [Cited by in Crossref: 106] [Cited by in F6Publishing: 91] [Article Influence: 5.3] [Reference Citation Analysis]
134 Rivera-Nieves J, Bamias G, Vidrich A, Marini M, Pizarro TT, McDuffie MJ, Moskaluk CA, Cohn SM, Cominelli F. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. Gastroenterology 2003;124:972-82. [PMID: 12671894 DOI: 10.1053/gast.2003.50148] [Cited by in Crossref: 124] [Cited by in F6Publishing: 121] [Article Influence: 6.2] [Reference Citation Analysis]
135 Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA. 2003;100:3455-3460. [PMID: 12626759 DOI: 10.1073/pnas.0530276100] [Cited by in Crossref: 231] [Cited by in F6Publishing: 243] [Article Influence: 11.6] [Reference Citation Analysis]
136 Kontoyiannis D, Boulougouris G, Manoloukos M, Armaka M, Apostolaki M, Pizarro T, Kotlyarov A, Forster I, Flavell R, Gaestel M, Tsichlis P, Cominelli F, Kollias G. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J Exp Med 2002;196:1563-74. [PMID: 12486099 DOI: 10.1084/jem.20020281] [Cited by in Crossref: 196] [Cited by in F6Publishing: 208] [Article Influence: 9.8] [Reference Citation Analysis]
137 Cominelli F, Arseneau KO, Pizarro TT. The mucosal inflammatory response. Cytokines and chemokines. Inflammatory Bowel Disease: From Bench to Bedside 2003. [DOI: 10.1007/978-1-4020-3477-0_7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
138 Shanahan F. The therapeutic use of probiotics in gastrointestinal inflammation. Functional Dairy Products 2003. [DOI: 10.1533/9781855736917.1.169] [Reference Citation Analysis]
139 Shanahan F. The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol 2002;16:915-31. [PMID: 12473298 DOI: 10.1053/bega.2002.0342] [Cited by in Crossref: 190] [Cited by in F6Publishing: 199] [Article Influence: 9.0] [Reference Citation Analysis]
140 Freeze HH. Sweet solution: sugars to the rescue. J Cell Biol 2002;158:615-6. [PMID: 12186848 DOI: 10.1083/jcb.200207155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
141 Dotan I, Mayer L. Immunopathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol 2002;18:421-7. [PMID: 17033316 DOI: 10.1097/00001574-200207000-00005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
142 Mueller C. Tumour necrosis factor in mouse models of chronic intestinal inflammation. Immunology 2002;105:1-8. [PMID: 11849309 DOI: 10.1046/j.1365-2567.2002.01329.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.0] [Reference Citation Analysis]
143 Kanai T, Watanabe M, Hibi T. Cytokine networks in the development of intestinal inflammation in Crohn's disease. Folia Pharmacol Jpn 2002;120:39-45. [DOI: 10.1254/fpj.120.39] [Reference Citation Analysis]
144 Burns RC, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Cominelli F, Ley K. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology 2001;121:1428-36. [PMID: 11729122 DOI: 10.1053/gast.2001.29568] [Cited by in Crossref: 158] [Cited by in F6Publishing: 163] [Article Influence: 7.2] [Reference Citation Analysis]
145 Papadakis KA, Prehn J, Moreno ST, Cheng L, Kouroumalis EA, Deem R, Breaverman T, Ponath PD, Andrew DP, Green PH, Hodge MR, Binder SW, Targan SR. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology 2001;121:246-54. [PMID: 11487533 DOI: 10.1053/gast.2001.27154] [Cited by in Crossref: 161] [Cited by in F6Publishing: 170] [Article Influence: 7.3] [Reference Citation Analysis]
146 Strober W, Nakamura K, Kitani A. The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease. J Clin Invest. 2001;107:667-670. [PMID: 11254665 DOI: 10.1172/jci12559] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
147 Kirsner JB. Crohn’s disease. Origins and Directions of Inflammatory Bowel Disease 2001. [DOI: 10.1007/978-94-010-0326-1_3] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]